Novo Nordisk is handing its Parkinson's stem cell therapy to a Zuckerberg-backed AI startup

Cellular Intelligence is acquiring STEM-PD, a Phase 2-ready cell therapy, and plans to use AI to accelerate development and manufacturing

Go to News Site